ENCODIA
Encodia is a biotech company that develops the next generation of protein analysis tools.
ENCODIA
Industry:
Biotechnology Chemical
Founded:
2015-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.encodia.com
Total Employee:
11+
Status:
Active
Contact:
858-345-6272
Total Funding:
75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Apache Mobile Non Scaleable Content Google Apps For Business
Similar Organizations
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
ARCH Venture Partners
ARCH Venture Partners investment in Series C - Encodia
Northpond Ventures
Northpond Ventures investment in Series C - Encodia
Decheng Capital
Decheng Capital investment in Series C - Encodia
GV
GV investment in Series C - Encodia
Biomatics Capital Partners
Biomatics Capital Partners investment in Series C - Encodia
Nan Fung Life Sciences
Nan Fung Life Sciences investment in Series C - Encodia
Deerfield
Deerfield investment in Series C - Encodia
Alexandria Venture Investments
Alexandria Venture Investments investment in Series C - Encodia
Tao Capital Partners
Tao Capital Partners investment in Series C - Encodia
Official Site Inspections
http://www.encodia.com Semrush global rank: 2.35 M Semrush visits lastest month: 7.88 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108

More informations about "Encodia"
Encodia
To solve our most challenging scientific problems, it takes looking at things from a novel perspective. ProteoCodeโข, our breakthrough reverse-translation technology, drives protein โฆSee details»
Encodia - Crunchbase Company Profile & Funding
Encodia provides in-depth information on cellular processes to enable personalized medicine. Our technology reverse translates peptide sequence information into a DNA library. This means โฆSee details»
Encodia Company Profile 2024: Valuation, Funding & Investors
Encodia General Information Description. Developer of a protein analysis software designed to enable democratized protein sequencing. The company's platform uses a novel reverse โฆSee details»
Encodia - The Org
Encodia is a privately held biotechnology company bringing the power of sequencing to proteomics. The company's patented ProteoCode technology enables highly scalable protein โฆSee details»
Encodia Company Overview, Contact Details & Competitors | LeadIQ
Jan 27, 2021 Encodia, Inc. received financing of $75M in Series C on Jan 29th '21. Encodia, a privately held biotech company developing next-generation solutions for proteomics research, โฆSee details»
Encodia - Company Profile - Tracxn
Nov 5, 2024 Encodia - Developer of technology platforms for integrative proteomic analysis. Raised a total funding of $75M over 4 rounds from 10 investors. Founded by Julie Sunderland, โฆSee details»
Encodia Company Profile - Office Locations, Competitors ... - Craft
Encodia is a biotech company developing ProteoCode, a reverse-translation technology for protein sequencing at scale. It enables next-generation sequencing-based protein analysis via โฆSee details»
Encodia - Overview, News & Similar companies | ZoomInfo.com
Oct 17, 2021 Who is Encodia. Encodia is a privately held biotechnology company bringing the power of sequencing to proteomics. The company's patented ProteoCode technology enab les โฆSee details»
Encodia - Org chart - The Org
Explore Encodia's organizational chart. Discover current team members including executives, board members, and advisors.See details»
Encodia - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 27, 2021: Series C - โฆSee details»
ENCODIA, INC. Company Profile | San Diego, CA - Dun & Bradstreet
Added by ENCODIA, INC. This information is updated and provided by ENCODIA, INC. The content available on the D&B Business Directory is provided "as-is" and "as-available" and โฆSee details»
Encodia - Updates, News, Events, Signals & Triggers - Crunchbase
Organization. Encodia . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Research and Development Insight Details. Powered by โฆSee details»
Encodia Company Profile | Management and Employees List
Find contact information for Encodia. Learn about their Research & Development, Business Services market share, competitors, and Encodia's email format.See details»
Encodia
Jan 26, 2021 Encodia is a privately held biotechnology company bringing the power of sequencing to proteomics. The company's patented ProteoCode technology enables highly โฆSee details»
Encodia - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Encodia . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Encodia has 5 current employee profiles, including Co โฆSee details»
Encodia, Inc - VentureRadar
Encodia is a rapidly growing platform company that is developing a new generation of protein analysis tools based on single-molecule protein sequencing. Our goal is to make protein โฆSee details»
Careers - Encodia
The possibilities are endless here at Encodia, and the culture is fantastic. I learn new things from every day!" Sarah Cebrynski Research Associate. Evolved benefits. Committed to your โฆSee details»
Technology - Encodia
Difficulties scaling proteomic studies have stifled its potential. But Encodiaโs ProteoCodeโข changes everything. Our groundbreaking technology reverse translates peptide sequence โฆSee details»
News - Encodia
Endpoints News - "Illumina co-founder Mark Chee moves from the genome to the proteome with upstart Encodia"See details»